Use of biologics as an adjunct therapy to arthroscopic surgery for the treatment of femoroacetabular impingement: a systematic review

Patrick G. Robinson*, Iain R. Murray, Julian Maempel, Conor S. Rankin, David Hamilton, Paul Gaston

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)
6 Downloads (Pure)


Background: There has been a recent increase in the use of biologics in hip arthroscopy to assist in the management of femoroacetabular impingement (FAI).

Purpose: To analyze the current use of biologics for the treatment of FAI and its associated lesions.

Study Design: Systematic review; Level of evidence, 4.

Methods: A search of the PubMed, Medline, and EMBASE databases was performed in March 2019 with use of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The criterion for inclusion was observational, published research articles studying the therapeutic use of biologics as an adjuvant therapy during arthroscopic surgery for FAI; treatments included bone marrow aspirate concentrate, mesenchymal stem cells (MSCs), platelet-rich plasma (PRP), hyaluronic acid, growth factors, and autologous chondrocyte implantation (ACI) or autologous matrix-induced chondrogenesis (AMIC).

Results: There were 9 studies that met the inclusion criteria, and a total of 674 patients were included across all studies. FAI was studied in all articles. Further, 7 studies (78%) also analyzed chondral injuries, and 3 studies also analyzed labral tears (33%). ACI or AMIC was used in 56% of studies and showed superior functional outcomes at short- and midterm follow-up versus debridement or microfracture. PRP did not improve the outcome of labral repairs at short-term follow-up.

Conclusion: The current literature regarding biologic adjuncts in hip arthroscopy is varied in quality, with only one level 1 study. The use of ACI/AMIC for medium-sized chondral lesions showed promising results in individual studies; however, these were of lower quality. To enable comparisons among future studies, investigators must ensure accuracy in the reporting of biologic preparations and formulations used and homogeneity in the type and severity of lesion treated.

Original languageEnglish
Number of pages9
JournalOrthopaedic Journal of Sports Medicine
Issue number12
Early online date30 Dec 2019
Publication statusPublished - Dec 2019


  • hip
  • arthroscopy
  • biologic healing enhancement
  • platelet-rich plasma

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine


Dive into the research topics of 'Use of biologics as an adjunct therapy to arthroscopic surgery for the treatment of femoroacetabular impingement: a systematic review'. Together they form a unique fingerprint.

Cite this